Page 2 - Atherosclerosis Repeatable Science Ushers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Atherosclerosis repeatable science ushers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Atherosclerosis Repeatable Science Ushers Today - Breaking & Trending Today

Natural obesity fighters: How coffee, tea, and cocoa combat weight gain

A review in Current Research in Food Science explores how bioactive compounds in coffee, tea, and cocoa combat obesity by inhibiting white adipogenesis and promoting brown adipogenesis and lipolysis. ....

Sanchari Sinha Dutta , Current Research In Food Science , Current Research , Food Science , Cardiovascular Disease , Public Health , Ignaling Pathway ,

High blood levels of TMAO predicts chronic kidney disease risk in future

New findings from Cleveland Clinic and Tufts University researchers show high blood levels of TMAO (trimethylamine N-oxide) predicts future risk of developing chronic kidney disease over time. ....

United States , Jan Bleeksma , Stanley Hazen , Meng Wang , Dariush Mozaffarian , Vascular Thoracic Institute , Human Health , Journal Of The American Society Nephrology , Friedman School , Food Is Medicine Institute , Tufts University , Cleveland Clinic Lerner Research Institute , Friedman School Of Nutrition Science , American Heart Association Postdoctoral Fellowship , National Institutes Of Health , Cleveland Clinic Center , Metabolic Sciences , Department Of Cardiovascular , Cleveland Clinic , American Society , Medicine Institute , Nutrition Science , National Institutes , Lerner Research Institute , Preventive Cardiology , Jan Bleeksma Chair ,

ZyVersa Therapeutics Highlights Published Data

Inhibiting inflammasome pathways has potential to attenuate atherosclerosis in patients with diabetes, a leading cause of morbidity & mortality.. ....

Stephenc Glover , Zyversa Therapeutics Inc , Biophysical Research Communications , Securities Exchange , Versa Therapeutics , Biophysical Research , Zyversa Therapeutics , Cholesterol Efflux Mediator , Securities Exchange Act , Private Securities Litigation Reform Act , Nasdaq Zvsa , Zyversa Therapeutics , Nflammasome Inhibition , Nflammasome Asc Inhibitor ,

Statins linked to slight diabetes risk but benefits outweigh the concerns

Statin use is associated with a moderate, dose-dependent increase in the risk of new-onset diabetes, particularly in individuals close to the diabetes threshold, yet the cardiovascular benefits of statin therapy remain substantial. ....

Lancet Diabetes , Image Credit , Cholesterol Treatment Trialist Collaboration , Cardiovascular Disease ,

Scientists find answers about cardiovascular diseases by probing the cellular "glue"

University of Virginia School of Medicine scientists have found important answers about strokes, heart attacks and cardiovascular diseases by probing the biological glue our bodies create to protect us from those deadly dangers. ....

United States , Manuel Mayr , Qi Cheng , Vaishnavi Karnewar , Aloke Finn , Sigrid Juse , Ferheen Baig , Saikat Ghosh , Konstantinos Theofilatos , Alicia Beele , Michael Joner , Garyk Owens , Santosh Karnewar , Zouhair Aherrahrou , Minnau Kaikkonen , American Heart Association , International Network Of Excellence , Finnish Foundation For Cardiovascular Research , National Institutes Of Health , Academy Of Finland , University Of Virginia School Medicine , Public Health Genomics , School Of Engineering , German Centre For Cardiovascular Research , Foundation Leducq , School Of Medicine ,